AMKR vs DXCM · P/E 37, rev $6.71B vs P/E 63, rev $2.50B
Amkor Technology Inc (AMKR) versus DexCom Inc (DXCM) — a side-by-side from cached financials, not a winner call.
Amkor Technology Inc (AMKR) is a semiconductor equipment & materials company listed on US.
DexCom Inc (DXCM) is a medical devices company listed on US.
Latest reported AMKR revenue for 2025-12-31 was $6.71B. Net income was $373.9M. Revenue was up 6.2% from 2024-12-31 to 2025-12-31. AMKR currently screens at market cap $16.10B and trailing P/E 37.3.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
AMKR currently screens at market cap $16.10B and trailing P/E 37.3. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Not investment advice. Open the AMKR and DXCM stock pages for the full models.
Not investment advice.